GlassScriptPhysician profile
Chad A Peterson
NPI 1629284732
$7,433.57
in general payments reported to CMS, 2019-2025
50 companies · $1,684 in 2025
The $1,684 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2020: $346 · 2021: $844 · 2022: $1,100 · 2023: $1,318 · 2024: $1,330 · 2025: $1,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,033 · Education: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,032.92 |
| Education | $298.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,399.76 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $768.47 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Sumitomo Pharma America, INC. | $672.42 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $436.11 | 2019-2025 | Provenge |
| Sun Pharmaceutical Industries INC. | $381.98 | 2019-2025 | Yonsa |
| Myriad Genetic Laboratories, INC. | $262.66 | 2020-2025 | Prolaris, Myrisk |
| Pfizer INC. | $262.36 | 2019-2025 | |
| Urogen Pharma, INC. | $259.81 | 2020-2025 | |
| Abbvie INC. | $213.86 | 2019-2025 | |
| Boston Scientific Corporation | $206.28 | 2019-2025 | Lumenis Pulse 120h, Rezum Generator |
| Astrazeneca Pharmaceuticals LP | $197.59 | 2021-2025 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $155.70 | 2021-2025 | |
| Procept Biorobotics Corporation | $151.99 | 2025 | |
| Coloplast Corp | $125.06 | 2021-2024 | |
| Myovant Sciences INC. | $123.76 | 2021-2022 |
Show all 49 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.